EGI
CCXI

EAM Global Investors’s ChemoCentryx, Inc. CCXI Stock Holding History

EAM Global Investors’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-32,809
Closed -$1.89M – 189
2020
Q2 		$1.89M Sell
32,809
-42,944
-57% -$2.34M 0.85% 47
2020
Q1 		$3.04M Sell
75,753
-7,857
-9% -$334K 1.78% 5
2019
Q4 		$3.31M Buy
+83,610
New +$1.47M 1.32% 10

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

EAM Global Investors's CCXI Position: Q3 2020 in Review

EAM Global Investors sold out of ChemoCentryx, Inc. (CCXI) in Q3 2020, closing a stake of 32,809 shares — an estimated $1.89M sold.

EAM Global Investors first reported a position in CCXI in Q4 2019 and held it in 3 quarters. The position peaked at $3.31M in Q4 2019. 204 funds tracked by Wall St. Rank hold CCXI as of Q3 2020.

  • EAM Global Investors reported no remaining ChemoCentryx, Inc. position as of Q3 2020 after selling out during the quarter.
  • EAM Global Investors sold 32,809 ChemoCentryx, Inc. shares in Q3 2020, an estimated $1.89M.
  • EAM Global Investors first reported a position in ChemoCentryx, Inc. in Q4 2019 and held it in 3 quarters.
  • EAM Global Investors's ChemoCentryx, Inc. position peaked at $3.31M in Q4 2019.
  • 204 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2020.

Based on EAM Global Investors's 13F filing for Q3 2020, filed 13 Nov 2020.